Mircera (methoxy polyethylene glycol-epoetin beta): Reviews and patient testimonials
Medication indications
Mircera solution for injection in pre-filled syringe
Treatment of symptomatic anaemia associated with chronic kidney disease (CKD) in adult patients.
Route of administration: Injectable
Molecule: methoxy polyethylene glycol-epoetin beta
Patients' opinions on Mircera
In brief
General satisfaction level: Be the first to evaluate
Treatment's effectiveness: Be the first to evaluate
Ease of use: Be the first to evaluate
Adherence to prescription: Be the first to evaluate
Detected side effects: Be the first to evaluate
Improvement in the quality of life: Be the first to evaluate
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.